Mineralys Therapeutics discloses 2022 executive bonuses and raises 2023 target bonus percentages

Mineralys Therapeutics, Inc.

2022 bonuses: CEO Congleton $193.2k, CFO Levy $190.9k, CMO Rodman $190.8k.
2023 target bonuses increased: Congleton 50% of base salary, Rodman 45%, Levy 40%.
Revised Summary Compensation Table includes previously omitted 2022 bonus amounts.
Equity awards in 2022: Congleton $1.12M stock, Levy $483.5k stock, Rodman $492k options.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.